ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Pavblu 40 mg/ml, Injektionslösung - 
69832001 Amgen Switzerland AG
Pavblu 40 mg/ml, Injektionslösung17.06.2025
  17.06.2025
Aflibercept (S01LA05) 
WHO-DDD16.06.2030
11.99. 
11.99. 
B  
Yes 
IP 
549.84Yes
    
10 %614.40
  
7680698320012Biotechnologika
  
Composition
afliberceptum 2 mg, saccharum, trehalosum dihydricum, polysorbatum 80, aqua ad iniectabile, ad solutionem pro 0.05 ml.
Packungsbestandteile
Injection solution 
  
 
Active AgentDose
Afliberceptum2mg / 0.05ml
BAG: Active AgentDose
Afliberceptum2 mg
 
Inactive agents
Polysorbatum 80
Saccharum
Trehalosum Dihydricum
 
Source
Data was imported : 19.11.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | Login | Contact | Home